arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

SI-BONE, Inc.

SIBN Health Care Medical/Dental Instruments
$21.45
▲ +3.0% Today
as of Oct 23, 10:36 ET
Last 30 days +15.27% Sep 14 → Oct 23
$17.76 $18.78 $19.80 $20.82 $21.84 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$20.93
High
$21.73
Low
$20.93
Volume
$525,822
Avg Vol
$599,069
Mkt Cap
$825M
P/E (TTM)
—
Beta
—
52w High
$21.89
52w Low
$11.48
Div Yield
—
Shares Out
$45M

Recent Press Releases & News last 60 days · 2 items

Aug 25 · 16:00 Zacks
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
Aug 24 · 13:55 Zacks
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

SIBN earnings at a glance

The options market is pricing a move of about ±5.6% after the report, a range of roughly $20.26 to $22.64 from today's $21.45. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.6% on average; after the most recent report on May 11, 2026 it moved -5.4%. That means options currently expect more movement than SIBN has typically delivered. SIBN beat the consensus EPS estimate in 4 of its last 4 reported quarters. Implied volatility is currently 47%. The share price of $21.45 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$11
$22
96% of range
Avg surprise (last 4)
+34.1%
Avg reaction (last 2)
-1.8%
50% positive
Latest IV / EM
47%
EM ±5.6% · $20 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.32$-0.26$-0.21$-0.15$-0.09 Actual $-0.32Actual $-0.30Actual $-0.25Actual $-0.27Actual $-0.22Actual $-0.16Actual $-0.15Est $-0.24Actual $-0.14Est $-0.19Actual $-0.11Est $-0.16Actual $-0.10Est $-0.17Actual $-0.09 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-7M$10M$26M$42M$59M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.09 — — — — financials
Mon May 11, 2026Mar/2026 $-0.10 $-0.17 +41.2% +33.3% -5.4% earnings
Mon Nov 10, 2025Sep/2025 $-0.11 $-0.16 +31.2% — — earnings
Mon Aug 4, 2025Jun/2025 $-0.14 $-0.19 +26.3% — — earnings
Mon May 5, 2025Mar/2025 $-0.15 $-0.24 +37.5% — +1.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.16 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.22 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.27 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.25 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.30 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.32 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$56M$53M—$49M$49M$47M—$40M
Cost of revenue$11M$11M—$10M$10M$10M—$8M
Gross profit$45M$42M—$39M$39M$38M—$32M
Operating income$-5M$-5M—$-5M$-7M$-7M—$-8M
Net income$-4M$-4M—$-5M$-6M$-7M—$-7M
EPS (diluted)$-0.09$-0.10—$-0.11$-0.14$-0.15—$-0.16

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$33M$34M$42M$26M$34M$41M$35M$30M
Inventory$38M$36M$34M$36M$34M$30M$27M$26M
Total current assets$220M$215M$216M$211M$207M$204M$208M$204M
Total assets$249M$243M$239M$234M$231M$227M$230M$227M
Long-term debt$36M$36M$36M$36M$36M$35M$35M$36M
Total liabilities$66M$64M$61M$62M$61M$60M$63M$62M
Total equity$182M$179M$178M$172M$170M$167M$167M$165M

Implied volatility — last 90 days

38%97%157%216%276% Jun 12 — IV 38% · EM ±3.9%Jun 19 — IV 67% · EM ±14.8%Jun 22 — IV 79% · EM ±16.4%Jun 23 — IV 61% · EM ±12.5%Jun 24 — IV 53% · EM ±10.6%Jun 25 — IV 45% · EM ±8.8%Jun 26 — IV 41% · EM ±7.8%Jun 29 — IV 44% · EM ±7.8%Jun 30 — IV 57% · EM ±9.8%Jul 01 — IV 48% · EM ±8.0%Jul 02 — IV 41% · EM ±6.6%Jul 03 — IV 42% · EM ±6.6%Jul 06 — IV 46% · EM ±6.4%Jul 07 — IV 44% · EM ±5.8%Jul 08 — IV 48% · EM ±6.1%Jul 09 — IV 47% · EM ±5.6%Jul 10 — IV 41% · EM ±4.6%Jul 13 — IV 50% · EM ±4.2%Jul 14 — IV 63% · EM ±4.6%Jul 15 — IV 74% · EM ±4.3%Jul 16 — IV 88% · EM ±3.7%Jul 20 — IV 76% · EM ±18.0%Jul 21 — IV 74% · EM ±17.3%Jul 22 — IV 91% · EM ±20.8%Jul 23 — IV 88% · EM ±19.7%Jul 24 — IV 91% · EM ±20.0%Jul 27 — IV 45% · EM ±9.4%Jul 28 — IV 70% · EM ±14.2%Jul 29 — IV 69% · EM ±13.8%Jul 30 — IV 51% · EM ±10.0%Jul 31 — IV 53% · EM ±10.1%Aug 03 — IV 73% · EM ±12.9%Aug 04 — IV 68% · EM ±11.8%Aug 05 — IV 126% · EM ±21.1%Aug 06 — IV 123% · EM ±19.8%Aug 07 — IV 84% · EM ±13.2%Aug 10 — IV 155% · EM ±21.5%Aug 11 — IV 135% · EM ±17.8%Aug 17 — IV 183% · EM ±15.2%Aug 24 — IV 52% · EM ±10.8%Aug 25 — IV 39% · EM ±8.1%Aug 26 — IV 89% · EM ±17.8%Aug 27 — IV 68% · EM ±13.3%Aug 31 — IV 79% · EM ±13.9%Sep 01 — IV 97% · EM ±16.6%Sep 02 — IV 80% · EM ±13.3%Sep 04 — IV 111% · EM ±17.3%Sep 09 — IV 80% · EM ±10.0%Sep 15 — IV 276% · EM ±20.0%Sep 21 — IV 68% · EM ±14.2%Sep 22 — IV 82% · EM ±16.7%Sep 23 — IV 71% · EM ±14.2%Sep 24 — IV 100% · EM ±19.6%Sep 25 — IV 97% · EM ±18.6%Sep 28 — IV 97% · EM ±17.1%Sep 29 — IV 52% · EM ±8.9%Sep 30 — IV 105% · EM ±17.6%Oct 08 — IV 47% · EM ±5.6%

Sector peers

SGP
SpyGlass Pharma, Inc.
$799M $27.74+0.1%
BBNX
Beta Bionics, Inc.
$952M $19.17+4.2%
IART
Integra LifeSciences Holdings Corporation
$1.0B $11.96+1.0%
PRCT
PROCEPT BioRobotics Corporation
$1.0B $19.64+7.5%
AORT
Artivion, Inc.
$1.1B $23.55+2.8%
ANGO
AngioDynamics, Inc.
$596M $12.29+3.3%

SIBN earnings FAQ

What is SIBN's expected move for earnings?

Options currently price a move of about ±5.6%, or $1.19 per share either way from $21.45.

How does SIBN stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.6%, up 1 times and down 1 times.

What is SIBN's implied volatility?

SIBN's at-the-money implied volatility is about 47% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in